Core Laboratories N.V.

Core Laboratories N.V. (CLB) Market Cap

Core Laboratories N.V. has a market capitalization of $596M.

Price: $12.93

-0.73 (-5.34%)

Market Cap: 596.03M

NYSE · time unavailable

CEO: Lawrence V. Bruno

Sector: Energy

Industry: Oil & Gas Equipment & Services

IPO Date: 1995-09-21

Website: https://www.corelab.com

Core Laboratories N.V. (CLB) - Company Information

Market Cap: 596.03M|Sector: Energy

Company Profile

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Analyst Sentiment

60%
Buy

From 3 Active Polls

1Y Forecast: $25.00

▲ +93.3% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$26

High Bound

$32

Average

$25

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$25.00
▲ +93.35% Upside
Low Target
$17.00
31% Risk
Median Target
$26.00
101% Mid
High Target
$32.00
147% Max
Consensus
Hold
16 / 37 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)596774745582547701811869937
Enterprise Value ($M)6147929297236958599721,0431,121
Price to Earnings Ratio (P/E)20.52-245.1137.6610.2212.86-1138.1927.3718.5125.94
Price/Earnings-to-Growth Ratio (PEG)13.573.052.426.3335.78
Price to Sales Ratio (P/S)1.146.355.394.334.205.676.276.477.18
Price to Book Ratio (P/B)2.172.812.662.142.092.773.223.473.90
Price to Free Cash Flow Ratio (P/FCF)31.47-835.38172.88106.3854.27227.5649.9383.8465.63
Enterprise Value to Sales (EV/Sales)6.506.725.385.346.957.527.768.58
Enterprise Value to EBITDA (EV/EBITDA)8.50140.1647.6329.5030.68106.0954.4744.4256.67
Debt to Equity Ratio0.260.150.740.620.680.710.710.780.84

CLB Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$12.93
Intrinsic Value$12.91
Market Alignment
Overvalued by 0.1%relative to calculated intrinsic value
9.00%
Exp: 0%0%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.05B
Perpetuity TV Value$0.96B
Discounted TV (PV)$0.41B
TV Weighting %57.7%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CORE LABORATORIES INC (CLB) — Investment Overview

🧩 Business Model Overview

Core Laboratories applies advanced reservoir and production characterization tools to help oil and gas operators make better capital allocation decisions and improve well performance. The value chain typically starts with subsurface data acquisition and laboratory/measurement work on reservoir rock and fluids. The company then integrates those measurements into reservoir models and applies proprietary technologies to quantify flow behavior, damage mechanisms, and production enhancement options. Outputs are delivered as analytical deliverables, technology-enabled services, and related software/data products that support drilling design, completion optimization, and ongoing production troubleshooting.

A key operating feature is that the company participates in the “decision lifecycle” for upstream assets—moving from early reservoir understanding to later-cycle performance improvement—while building an increasingly reusable knowledge base tied to measured reservoir properties and validated methodologies.

💰 Revenue Streams & Monetisation Model

Monetisation is driven by a mix of (1) technology-enabled, project-based consulting and laboratory services and (2) technology and data-related revenue that can recur as operators engage the firm across multiple assets or phases of field development. Margin drivers include:

  • Proprietary technology utilization: Higher-value engagements where clients pay for specific models, interpretation frameworks, and production enhancement pathways.
  • Lab and technical execution leverage: Repeatable workflows, standardized measurement/interpretation approaches, and scaling of trained technical capacity.
  • Recurring client “workstream” development: While end markets are cyclical, many clients return when results are incorporated into reservoir decision-making and troubleshooting protocols.

Overall, revenue is not a pure subscription model, but the economics benefit when Core’s analytical outputs become embedded in customer reservoir models and operating processes.

🧠 Competitive Advantages & Market Positioning

Core’s moat centers on intangible assets and switching costs built from proprietary datasets, validated reservoir characterization methods, and a long history of domain-specific laboratory work. Competitors can match portions of technical capability, but replicating the full set of calibrated know-how and reference frameworks takes time and extensive validation.

Switching costs / data gravity: Once Core’s measurements and interpretations are integrated into an operator’s reservoir models—affecting well design assumptions, stimulation strategy, and production forecast logic—changing vendors typically requires rework, re-calibration, and re-validation of subsurface models. This creates an economic and technical friction that supports customer stickiness.

Intangible knowledge moat: The firm’s credibility and differentiation depend on accumulated subsurface experience and proprietary analytical frameworks, which benefit from cumulative learning and repeat application across asset types.

Competitive benchmarking:

  • Schlumberger (SLB): Broad integrated oilfield services provider with strong geoscience and reservoir capabilities across the project lifecycle.
  • Halliburton (HAL): Large footprint in stimulation, cementing, and subsurface services, competing for reservoir-to-well execution work.
  • Baker Hughes (BKR): Focus across equipment and services with competing offerings in subsurface characterization and production optimization.

Core’s positioning differs in emphasis: whereas large diversified service companies often deliver integrated solutions at scale, Core concentrates on high-value reservoir and production characterization where proprietary lab/analytics and interpretation frameworks can materially influence technical decisions. The competitive contrast is less about geographic field presence and more about depth of subsurface measurement, technology specificity, and model integration.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand for better subsurface decisions rather than only incremental rig activity. Key drivers include:

  • Brownfield optimization: Mature fields increasingly require improved understanding of heterogeneity, wellbore damage, reservoir connectivity, and incremental recovery opportunities—areas where characterization and validation matter.
  • Enhanced oil recovery and complex reservoirs: Greater focus on EOR mechanisms and production challenges in tighter formations raises the value of measurement-grade reservoir understanding and flow diagnostics.
  • Digital and model-driven operations: Operators expand use of simulation, data integration, and analytics. Proprietary measurement workflows and validated interpretation frameworks can support more reliable model inputs.
  • Risk reduction for capital allocation: With cost pressure and lower tolerance for forecasting errors, operators pay for better subsurface certainty prior to major capital commitments.

The implied TAM expands as more assets move toward data-intensive development and troubleshooting phases, and as operators demand higher technical confidence in reservoir performance.

⚠ Risk Factors to Monitor

  • Upstream capital cycle volatility: Oil and gas operators manage spend tightly; project-based technical services can experience demand swings tied to commodity prices and E&P budgets.
  • Competitive substitution risk: Large diversified oilfield services players can bundle reservoir characterization with other offerings. Even when Core’s technology is preferred, budget trade-offs can shift workshare.
  • Technological and methodological obsolescence: Advancements in measurement, interpretation, and simulation can reduce the relative value of existing approaches if proprietary differentiation is not maintained.
  • Customer concentration and procurement cycles: Procurement processes at major operators can introduce timing and scale variability across asset programs.
  • Intellectual property and data integrity: The business depends on proprietary methods and accumulated knowledge; litigation, reputational risk, or data handling failures could affect competitiveness.
  • Operational execution in technical delivery: Laboratory quality, turnaround time, and interpretation rigor are central to client trust; execution issues can harm renewal probability.

📊 Valuation & Market View

Equity valuation in oilfield services and energy technology typically reflects earnings power through the cycle and the degree of defensibility in revenue mix. Markets often use EV/EBITDA and EV/EBIT as primary frameworks, while investors may assign incremental value when technology-like characteristics—such as proprietary intellectual capital, repeatable service delivery, and model-embedded outputs—reduce cyclicality.

Multiple expansion or contraction tends to track:

  • Visibility and renewal behavior: Evidence that client engagements extend across asset lifecycles.
  • Operating leverage: How efficiently fixed technical capacity converts into profit during upcycles.
  • Mix shift toward higher-value technology work: Greater share of specialty analytics and production enhancement rather than lower-margin commodity-like work.
  • Balance sheet and free cash flow resilience: Ability to fund capacity and technology while navigating industry downcycles.

🔍 Investment Takeaway

Core Laboratories offers a differentiated, technology-led positioning in upstream reservoir and production optimization. The central investment thesis rests on intangible knowledge assets and customer switching costs created by embedding proprietary measurements and interpretations into operator reservoir models and decision workflows. While demand remains tied to upstream spending discipline, the durability of the technology-and-data moat supports the prospect of above-average long-term profitability if the company sustains validation, execution quality, and technological relevance against large integrated competitors.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CLB.

zacks.com2026-05-29

Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

zacks.com2026-05-21

Implied Volatility Surging for Core Laboratories Stock Options

Investors need to pay close attention to CLB stock based on the movements in the options market lately.

zacks.com2026-05-04

Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y

CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.

seekingalpha.com2026-04-30

Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript

prnewswire.com2026-04-29

CORE LAB REPORTS FIRST QUARTER 2026 RESULTS

REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR GAAP LOSS PER SHARE OF $0.02 ; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEAR FREE CASH FLOW OF $0.5 MILLION NET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20 COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND HOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all in accordance with U.S. generally accepted accounting principles ("GAAP").

zacks.com2026-04-29

DTI or CLB: Which Is the Better Value Stock Right Now?

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com2026-04-23

Core Laboratories to Post Q1 Earnings: Key Metrics to Watch

CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.

zacks.com2026-04-22

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-04-13

DTI vs. CLB: Which Stock Is the Better Value Option?

Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-03-27

DTI vs. CLB: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com2026-03-25

Middle East Conflict Weighs On Core Laboratories' Q1 Outlook

CLB's operations remain disrupted amid geopolitical tensions, forcing a cut in Q1 2026 guidance due to supply chain issues and weaker client activity.

zacks.com2026-03-24

Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now

CLB is supported by offshore expansion, high-margin services and innovation, but pressured by geopolitical tensions, soft U.S. markets and oil price uncertainty.

prnewswire.com2026-03-23

CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE

HOUSTON, March 23, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle East and its effect on the Company's first quarter 2026 financial results. Core Lab is working with clients and its local teams to manage operations and mitigate impacts on project execution through a rapidly changing operating environment. The safety and security of the Company's employees remain its highest priority.

defenseworld.net2026-03-13

Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

Core Laboratories Inc. (NYSE: CLB - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $15.60 and traded as high as $16.29. Core Laboratories shares last traded at $15.8820, with a volume of 330,035 shares trading hands. Wall Street Analysts Forecast

zacks.com2026-03-11

DTI or CLB: Which Is the Better Value Stock Right Now?

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Q1 2026 results: Revenue $121.8M (QoQ: -11.9%; YoY: -1.4%). Net income was -$0.8M vs -$0.2M in Q1 2025 and +$7.1M in Q4 2025; EPS -$0.02. Profitability weakened sharply this quarter: net margin turned negative (-0.7%) after positive margins in prior quarters (Q4 2025: +5.1%). Over the last four reported quarters, the company showed higher earnings earlier in the year before the recent downturn. Operating income in Q1 2026 was +$1.9M (operating margin +1.5%), down from Q4 2025 (+10.4%) and Q3 2025 (+15.6%), indicating margin compression driven by elevated operating/other expense lines. Cash flow held up despite the loss: Q1 2026 operating cash flow was +$4.0M and free cash flow +$4.0M, while dividends were paid (-$0.46M) and buybacks continued (-$4.0M). Balance sheet resilience looks mixed: total assets fell slightly QoQ ($587.7M vs $597.0M), equity was stable in level terms ($275.1M vs $279.8M), and leverage appears manageable with net debt around $18.5M. Total shareholder return is supportive given strong 1-year price momentum (+33.9%) with a small dividend yield (~0.06%)—so the equity story is currently driven more by capital appreciation than income."

Revenue Growth

Fair

Revenue fell QoQ (121.8M vs 138.3M, -11.9%) and is slightly down YoY (vs 123.6M, -1.4%), suggesting a soft top-line quarter.

Profitability

Neutral

Net income turned negative (-$0.8M) after positive profitability in Q4 2025 (+$7.1M). Net margin contracted from +5.1% (Q4) to -0.7% (Q1), indicating significant margin compression.

Cash Flow Quality

Neutral

Operating cash flow remained positive (+$4.0M) and free cash flow was +$4.0M despite the net loss. Dividends were paid (-$0.46M) and buybacks continued (-$4.0M).

Leverage & Balance Sheet

Positive

Balance sheet stability: total assets slightly declined QoQ ($587.7M vs $597.0M) and equity was largely steady ($275.1M vs $279.8M). Net debt is low (~$18.5M), implying resilience.

Shareholder Returns

Positive

Strong price momentum with 1y_change of +33.9% materially lifts total return. Dividend yield is small (~0.06%), so most return is capital appreciation.

Analyst Sentiment & Valuation

Neutral

Current price $16.50 is below the consensus target ($25). However, the near-term earnings deterioration (net loss this quarter) limits confidence in upside timing.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Core Laboratories’ Q1 2026 performance was decisively pressured by geopolitical and weather shocks. Revenue fell 12% sequentially to $121.8M and ex-items diluted EPS dropped to $0.06 from $0.21, while Reservoir Description margins compressed ~800 bps sequentially to 6% and Production Enhancement fell to 5% from 7%. Service economics deteriorated: cost of services rose to 81% of service revenue from 75% as Middle East disruptions abruptly suspended assay-related revenue but left costs intact. DSOs increased to 74 days due to slower collections. Despite the near-term hit, the business remains active with differentiated technology traction: GTX X-Band/Expand delivered a large water-cut reduction and a follow-on 10-well campaign, while FLOWPROFILER results drove additional 5-well deployment plans. Guidance for Q2 calls for revenue $123M–$131M and EPS $0.06–$0.12, still modestly constructive but reflecting continued volatility, tariff/supply chain sensitivity, and operational restoration risk. Sentiment is cautious.

AI IconGrowth Catalysts

  • Integrated digital data strategy: delivery of key reservoir data sets via proprietary rapid platform to standardize/digitize reservoir data for faster client workflow integration and turnaround times
  • Production Enhancement water-cut reduction using GTX X-Band for harsh cyclic steam injection (600°F) and follow-on campaign expansion: 10-well additional campaign for the Middle East national oil company
  • FLOWPROFILER solid oil tracers deployed across a 30-stage Permian horizontal well; stage-by-stage oil contribution insights leading to planned deployment in 5 additional wells

Business Development

  • Middle East national oil company: deployed GTX Expand Extreme High temperature casing patch / GTX X-Band to address excess water production; initiated additional 10-well campaign
  • Independent operator in the Permian Basin: deployed FLOWPROFILER solid oil tracers in a 30-stage horizontal well; plans FLOWPROFILER deployment in 5 additional wells

AI IconFinancial Highlights

  • Reported revenue $121.8M: down 12% sequentially and down 1% YoY (seasonal decline plus Middle East conflict and severe weather)
  • EPS (diluted, ex items) $0.06: down from $0.21 in prior quarter; down from $0.14 YoY
  • Reservoir Description operating margin ex items: 6% vs nearly 800 bps sequential decline from Q4 2025
  • Production Enhancement operating margin ex items: 5% vs 7% in Q4 2025 (sequential margin compression driven by Middle East disruption, delayed energetic shipments, and North America cold weather/temporary manufacturing closures)
  • Service revenue mix deterioration: cost of services ex items was 81% of service revenue vs 75% in prior quarter (sharp sequential increase tied to Middle East revenue suspension)
  • DSOs increased to 74 days from 69 due to Middle East revenue disruption and slower collections
  • Net loss on GAAP basis: -$0.02 diluted EPS; operating income ex items: $6.6M (EBIT margin >5%) vs $15.7M last quarter
  • Interest expense $2.9M vs $2.6M prior quarter; increase linked to higher-rate new term loan used to retire $45M senior notes in Jan 2026
  • Tax assumptions: guidance excludes FX; uses effective tax rate 25%; Q1 ex-items tax expense $0.9M (GAAP tax benefit $0.3M)

AI IconCapital Funding

  • Share repurchase: repurchased 51,000+ shares valued at approximately $0.9M; stated as the sixth consecutive quarter of buybacks
  • Free cash flow: $0.5M in Q1 (operating cash flow $4M less ~ $3.5M CapEx)
  • CapEx: $1.4M in Q1 for U.K. facility rebuild (covered by property/casualty insurance and excluded from free cash flow); full-year 2026 CapEx expected $15M to $18M excluding rebuild costs
  • Balance sheet: long-term debt $117M at Mar 31, 2026; cash $22.8M; net debt $94.2M (up $3.9M sequentially)
  • Credit/debt actions: drew $50M on term loan in Q1 2026; retired $45M senior notes in January 2026
  • Leverage ratio ~1.2 vs 1.1% last quarter (as stated on call)

AI IconStrategy & Ops

  • Temporary closures and operational disruption: severe cold weather closed Core Lab manufacturing facilities (North America) and Storm Harry suspended demand across several Mediterranean countries; facility damage in the Mediterranean under restoration
  • Asset-light/cost management: continued focus on cost structure management during temporary regional disruptions; G&A ex items $11.0M, with 2026 target $42M to $45M
  • Digital productization: rapid platform structured data sets to support client workflow integration and foundational data for AI initiatives
  • Shipment/energetic constraints: Middle East conflict delayed or suspended energetic shipments; contributed to delayed completion diagnostic field programs

AI IconMarket Outlook

  • Macro inputs cited: IEA/EIA/OPEC forecast 2026 crude oil demand growth of ~600,000 to 1.4M bpd; global supply disruptions reduced global crude oil supply by ~20% (including Strait of Hormuz closure and refining infrastructure damage)
  • Q2 2026 guidance (excluding FX gains/losses; assumes effective tax rate 25%):
  • Reservoir Description revenue $77.5M to $82.5M; operating income $3.5M to $5.4M
  • Production Enhancement revenue $45.5M to $48.5M; operating income $2.8M to $4.7M
  • Total Q2 2026 revenue $123M to $131M; total operating income $6.4M to $10.2M; operating margin ~7%
  • Q2 2026 EPS expected $0.06 to $0.12

AI IconRisks & Headwinds

  • Middle East conflict: closed many client offices, delayed project execution and slowed field access for sample acquisition; disrupted maritime hydrocarbon transportation and reduced demand for Reservoir Description and Production Enhancement service-side activities
  • Extended impact on global assay network: disruption in maritime trading routes impacts Core’s lab network beyond the Middle East
  • Russia/Ukraine geopolitical conflict: further negative demand impact for assay services
  • Sanctions and infrastructure attacks: evolving western sanctions and attacks on transportation/refining infrastructure create demand uncertainties and operational inefficiencies
  • Weather volatility: severe North America cold weather reduced onshore completion activities and temporarily closed manufacturing facilities; Mediterranean Storm Harry caused demand suspension and facility damage
  • Collection and working-capital pressure: DSOs increased to 74 days; inventory turns declined with lower international bulk sales
  • Margin pressure from revenue suspension and cost absorption: cost of services as % of service revenue rose to 81% from 75% sequentially
  • Tariff/supply chain exposure: increasing costs for imported raw materials used in Production Enhancement; subject to tariffs and supply chain volatility

Q&A: Analyst Interest

  • Topic: Middle East disruption normalization and whether Core infrastructure is damaged: Management confirmed no damage to any Core infrastructure, emphasized that revenue flow halted while costs remained, described a scenario for a rapid rebound tied to restored maritime oil movement and reopening of offices/field access, and referenced early ceasefire indications of recovery.
  • Topic: Physical vs paper market disconnect and urgency for energy security-driven resource development: Management linked the situation to strategic reserve drawdowns (~400M barrels cited) versus disrupted Middle East flow (~20M bpd cited) and quickly consumed inventories, arguing investors will pursue longer-term reinvestment and localized development, referencing reinvestment shifts pre-war in Malaysia/Indonesia and canal-avoidance concerns.
  • Topic: (Third Q&A item not fully present in provided transcript) Management’s detailed response: The transcript provided only includes two complete analyst questions; no third analyst topic is visible after the excerpt ends mid-sentence, so no management response can be accurately extracted without additional transcript text.

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the CLB Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CLB.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (CLB)

© 2026 Stock Market Info — Core Laboratories N.V. (CLB) Financial Profile